A tipping point for drug prices?

The pharmaceutical industry has a new villain and his name is Martin Shkreli, Tabitha M. Powledge writes: "It helps that Shkreli is very nearly a caricature — or maybe I mean the Platonic idea — of the rapacious capitalist. For one thing, he’s a former hedge fund manager, a job description so vilified that even some tax-averse Republican presidential candidates have declared it a target." Also, the Pope's "pointed indirection" with Congress, and the moon's showstopper.

September 26, 2015

ADVERTISEMENT
EurekAlert! Travel Awards

ADVERTISEMENT
Sharon Begley Science Reporting Award

ADVERTISEMENT
Advertise with NASW